greater/cannabis

TECHNICAL FIELD This disclosure relates generally to products including at least one cannabinoid, and particularly to formulated cannabinoid products including a carrier or excipient that is an anti-oxidant. BACKGROUND OF THE INVENTION The medicinal use of oils and extracts derived from cannabis

FIELD OF THE INVENTION The present invention relates generally to cannabinoid analogs and is more particularly concerned with new and improved retro-anandamide cannabinoid analogs exhibiting high binding affinities for cannabinoid receptors, pharmaceutical preparations employing these analogs and

FIELD OF THE INVENTION This invention relates to topical formulations that comprise a Cannabis derived botanical drug product, methods of making the topical formulations, and methods of using the topical formulations in treating dermatological diseases. BACKGROUND OF THE INVENTION The botanical

FIELD OF THE INVENTION This invention relates to topical formulations that comprise a Cannabis derived botanical drug product, methods of making the topical formulations, and methods of using the topical formulations in treating dermatological diseases. BACKGROUND OF THE INVENTION The botanical

FIELD OF THE INVENTION This invention relates to topical formulations that comprise a Cannabis derived botanical drug product, methods of making the topical formulations, and methods of using the topical formulations in treating dermatological diseases. BACKGROUND OF THE INVENTION The botanical

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not Applicable FIELD OF THE INVENTION The present invention is directed to the field of cannabinoid plant extracts and cannabinoid active agents, especially to cannabidiol (CBD), cannabidiolic acid (CBD Acid), tetrahydrocannabinol

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not Applicable FIELD OF THE INVENTION The present invention is directed to the field of cannabinoid plant extracts and cannabinoid active agents, especially to cannabidiol (CBD), cannabidiolic acid (CBD Acid), tetrahydrocannabinol

This application is a National Stage application under 35 U.S.C. .sctn. 371 of International Application No. PCT/GB2017/050868, having an International Filing Date of Mar. 28, 2017, which claims the benefit of United Kingdom Application Serial No. 1605448.8 filed Mar. 31, 2016. This disclosure of